Literature DB >> 2728855

Long-term clinical and neurophysiological effects of reconstructive vascular surgery for cerebral ischemia.

A W de Weerd1, R J Veldhuizen, M M Veering, D C Poortvliet, E J Jonkman.   

Abstract

In a series of patients with unilateral supratentorial ischemia, clinical scores and parameters derived from computer analysis of the EEG and from measurement of the CBF were determined in the first several weeks after the stroke. Seventeen of these patients underwent a carotid-endarterectomy and 15 a STA-MCA bypass operation. Matched control patients were selected from the remaining cases. All patients, including the controls, were eligible for vascular surgery. The measurements were repeated respectively 3 months and 3 years after the first examination. Clinical improvement occurred in all groups. The degree of these clinical changes was similar for operated and non operated cases. EEG changes indicated more improvement in the cases without surgery. Finally, the CBF was remarkably stable in all patients. The overall effects of reconstructive vascular surgery on the recovery after cerebral ischemia appeared to be negligible.

Entities:  

Mesh:

Year:  1989        PMID: 2728855     DOI: 10.1111/j.1600-0404.1989.tb03791.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Superficial temporal artery to middle cerebral artery bypass.

Authors:  David W Newell
Journal:  Skull Base       Date:  2005-05

2.  Subtyping of psychiatric patients by cluster analysis of QEEG.

Authors:  E R John; L S Prichep; M Almas
Journal:  Brain Topogr       Date:  1992       Impact factor: 3.020

3.  QEEG profiles of psychiatric disorders.

Authors:  L S Prichep; E R John
Journal:  Brain Topogr       Date:  1992       Impact factor: 3.020

4.  Neurometrics in cerebral ischemia and uremic encephalopathy.

Authors:  J Jonkman; A W de Weerd; D C Poortvliet; R J Veldhuizen; H van Duijn; C A Rozeman; M Laman
Journal:  Brain Topogr       Date:  1992       Impact factor: 3.020

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.